GGrantIndex
Sort

166,118 grants matching stem cells

Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells

$833,765
Leslie Michels Thompson · University Of California-Irvine · U54 · FY2018 · NS

CAREER: Illuminating O-GlcNAc-Driven Functions of the Human Proteome

$833,727
Charlie Fehl · Wayne State University · · FY2023 · MPS

Biosynthesis, Regulation and Engineering of C-Lignin

$833,722
Richard A Dixon · University Of North Texas · · FY2015 · BIO

Multi-Omics for Maternal Health after Preeclampsia

$833,689
Louise Chang Laurent · University Of California, San Diego · U01 · FY2023 · HG

Neuroscience Resident Research Program

$833,656
Sydney S Cash · Massachusetts General Hospital · R25 · FY2021 · NS

Evolving High Potency AAV Vectors for Neuromuscular Genome Editing

$833,603
Aravind Asokan · Duke University · UH3 · FY2021 · AR

Towards renal regeneration

$833,539
University Of Queensland · R01 · FY2004 · DK

BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD) - TASK AREA B

$833,473
Joseph Wu · Stanford University · N01 · FY2022 · HL

Engineering synthetic immune cells with modular sentinel and therapeutic functions for T1D

$833,374
Wendell A Lim · University Of California, San Francisco · R01 · FY2025 · DK

Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy

$833,369
Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2018 · CA

Tissue chips for precision treatment of catecholaminergic polymorphic ventricular tachycardia

$833,368
William T Pu · Boston Children'S Hospital · UH3 · FY2023 · TR

Discovery and Analysis Project

$833,332
Louis H. Philipson · University Of Chicago · U54 · FY2025 · DK

Interventions that Retard Mamalian Aging

$833,308
David E Harrison · Jackson Laboratory · U01 · FY2010 · AG

Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche

$833,270
Russell S Taichman · University Of Michigan At Ann Arbor · U54 · FY2015 · CA

Functional characterization of Alzheimer's disease associated genetic variants

$833,263
Yin Shen · University Of California, San Francisco · R01 · FY2018 · AG

Optimization of a potent and cell active CK2 chemical probe for Alzheimer's disease therapy

$833,173
Alison Donnelly Axtman · Univ Of North Carolina Chapel Hill · R56 · FY2024 · AG

Centrosome Regulation in Development and Dysregulation in Disease

$833,147
Nasser Rusan · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

Pathological Mechanisms of Human Cerebellar Malformations

$833,091
Kathleen Joyce Millen · Seattle Children'S Hospital · R37 · FY2021 · NS

Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain

$833,050
Peter C Searson · Johns Hopkins University · R61 · FY2021 · HL

Immune signatures of CMV disease risk after orthotopic liver transplant

$832,910
Emily Ford · University Of Washington · R01 · FY2025 · AI

Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV

$832,882
Qing Ma · State University Of New York At Buffalo · R01 · FY2021 · AG

BONE MARROW FAILURE CLINICAL RESEARCH CENTER

$832,818
Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · U54 · FY2008 · RR

Effects of 16p11.2 copy number variation on neuronal development and pathology

$832,810
Mustafa None Sahin · Boston Children'S Hospital · R01 · FY2024 · MH

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$832,771
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection

$832,743
Gaya K. Amarasinghe · Washington University · R01 · FY2019 · AI